These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22115534)
21. Correlations between in vivo (1)H MRS and ex vivo (1)H HRMAS metabolite measurements in adult human gliomas. Opstad KS; Wright AJ; Bell BA; Griffiths JR; Howe FA J Magn Reson Imaging; 2010 Feb; 31(2):289-97. PubMed ID: 20099340 [TBL] [Abstract][Full Text] [Related]
22. Repeatability of edited lactate and other metabolites in astrocytoma at 3T. McLean MA; Sun A; Bradstreet TE; Schaeffer AK; Liu H; Iannone R; Herman G; Railkar RA; Joubert I; Gillard JH; Price SJ; Griffiths JR J Magn Reson Imaging; 2012 Aug; 36(2):468-75. PubMed ID: 22535478 [TBL] [Abstract][Full Text] [Related]
23. MR spectroscopy differentiation between high and low grade astrocytomas: a comparison between paediatric and adult tumours. Porto L; Kieslich M; Franz K; Lehrnbecher T; Zanella F; Pilatus U; Hattingen E Eur J Paediatr Neurol; 2011 May; 15(3):214-21. PubMed ID: 21145271 [TBL] [Abstract][Full Text] [Related]
24. [Functional imaging for brain tumors (perfusion, DTI and MR spectroscopy)]. Essig M; Giesel F; Stieltjes B; Weber MA Radiologe; 2007 Jun; 47(6):513-9. PubMed ID: 17505814 [TBL] [Abstract][Full Text] [Related]
25. Adult brain tumors: clinical applications of magnetic resonance spectroscopy. Brandão LA; Castillo M Neuroimaging Clin N Am; 2013 Aug; 23(3):527-55. PubMed ID: 23928203 [TBL] [Abstract][Full Text] [Related]
27. Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo-inositol and glycine levels. Londoño A; Castillo M; Armao D; Kwock L; Suzuki K AJNR Am J Neuroradiol; 2003 May; 24(5):942-5. PubMed ID: 12748098 [TBL] [Abstract][Full Text] [Related]
28. P-31 MR spectroscopy of normal human brain and brain tumors. Hubesch B; Sappey-Marinier D; Roth K; Meyerhoff DJ; Matson GB; Weiner MW Radiology; 1990 Feb; 174(2):401-9. PubMed ID: 2296651 [TBL] [Abstract][Full Text] [Related]
29. [MR perfusion and spectroscopic imaging in WHO grade II astrocytomas]. Weber MA; Vogt-Schaden M; Bossert O; Giesel FL; Kauczor HU; Essig M Radiologe; 2007 Sep; 47(9):812-8. PubMed ID: 16924439 [TBL] [Abstract][Full Text] [Related]
30. Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma. Cirak B; Horská A; Barker PB; Burger PC; Carson BS; Avellino AM Childs Nerv Syst; 2005 May; 21(5):404-9. PubMed ID: 15372294 [TBL] [Abstract][Full Text] [Related]
31. Discrimination of brain abscess and cystic tumor by in vivo proton magnetic resonance spectroscopy. Kadota O; Kohno K; Ohue S; Kumon Y; Sakaki S; Kikuchi K; Miki H Neurol Med Chir (Tokyo); 2001 Mar; 41(3):121-6. PubMed ID: 11372554 [TBL] [Abstract][Full Text] [Related]
32. Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective. Tihan T; Vohra P; Berger MS; Keles GE J Neurooncol; 2006 Jan; 76(2):175-83. PubMed ID: 16132490 [TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of two different nuclear magnetic resonance (NMR) approaches to imaging of a low grade astrocytoma. Buonanno FS; Pykett IL; Brady TJ; Black P; New PF; Richardson EP; Hinshaw WS; Goldman M; Pohost G; Kistler JP J Comput Assist Tomogr; 1982 Jun; 6(3):529-35. PubMed ID: 7096702 [No Abstract] [Full Text] [Related]
34. [Phosphorus-31 MR spectroscopy of brain tumors]. Miyamachi K; Abe H; Miyasaka K No Shinkei Geka; 1990 Jun; 18(6):533-7. PubMed ID: 2395512 [TBL] [Abstract][Full Text] [Related]
35. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. De Stefano N; Caramanos Z; Preul MC; Francis G; Antel JP; Arnold DL Ann Neurol; 1998 Aug; 44(2):273-8. PubMed ID: 9708554 [TBL] [Abstract][Full Text] [Related]
36. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Fountas KN; Kapsalaki EZ; Vogel RL; Fezoulidis I; Robinson JS; Gotsis ED Stereotact Funct Neurosurg; 2004; 82(2-3):90-7. PubMed ID: 15305081 [TBL] [Abstract][Full Text] [Related]
37. Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas. Guillevin R; Menuel C; Abud L; Costalat R; Capelle L; Hoang-Xuan K; Habas C; Chiras J; Vallée JN J Magn Reson Imaging; 2012 Mar; 35(3):543-50. PubMed ID: 22045581 [TBL] [Abstract][Full Text] [Related]
38. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. Hollingworth W; Medina LS; Lenkinski RE; Shibata DK; Bernal B; Zurakowski D; Comstock B; Jarvik JG AJNR Am J Neuroradiol; 2006 Aug; 27(7):1404-11. PubMed ID: 16908548 [TBL] [Abstract][Full Text] [Related]
39. Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis. Majós C; Alonso J; Aguilera C; Serrallonga M; Acebes JJ; Arús C; Gili J Radiology; 2002 Nov; 225(2):556-66. PubMed ID: 12409595 [TBL] [Abstract][Full Text] [Related]
40. Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. Tzika AA; Cheng LL; Goumnerova L; Madsen JR; Zurakowski D; Astrakas LG; Zarifi MK; Scott RM; Anthony DC; Gonzalez RG; Black PM J Neurosurg; 2002 Jun; 96(6):1023-31. PubMed ID: 12066902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]